Andreas Bauer Email & Phone Number

Basel, Switzerland

• Overseeing diligence activities (IN-bound, OUT-bound) for BD&L and M&A across different therapeutic areas• Providing strategic guidance on concrete opportunities under assessment, and supporting diligence leads in preparation for key governance decisions and required stakeholder management• Ensuring high-quality of partnering DD process for IM and acting as primary interface with broader DD community across the organization• Directly managing a group of due diligence directors for in-bound / out-bound diligences• Accountable for the training needs of the DD group

Basel, Switzerland

• Leading global cross-functional due diligence (DD) teams for robust, balanced, and timely DD evaluations across different development units• Key partner for BD&L to support Mergers & Acquisitions, In-licensing, and Option and Partnering deals• Reporting of diligence findings and providing guidance / recommendations to senior management • Successful execution of deals for Novartis’ key strategic areas • Supporting the Center of Excellence DD for process development and implementation of a harmonized diligence process across different divisions and functions (process development, tool building, training material, webpages, DD reports, digital tools)• Providing mentorship to junior colleagues and best practice and knowledge sharing within broader DD community

Basel, Switzerland

• Leading a cross-functional drug discovery project team focused on hepatology indications• Design and implementation of Lead-/Target-finding and validation strategies• Supervision of a research lab with lab heads, post doc and lab associates

Basel; Switzerland

• Supervised cross-functional drug discovery project teams focused on Hepatology and Oncology indications• Accountable for providing leadership directions for project implementation and to communicate concepts and progress to key stakeholders

Basel; Switzerland

• Led a multi-national and cross-functional drug discovery project team to systematically identify and validate epigenetic regulators for Oncology indications• Development of project strategy for the initiation of early drug development activities in close dialog with Novartis senior management

Basel; Switzerland

• Established and ran proteomics core facility at Novartis • Primary project partner for target identification activities at Novartis via Proteomics/ Mass spectrometry • Supervised a cross-functional team of 10 scientists

Heidelberg; Germany

• Established and ran the Biochemistry core facility with 10+ scientists / associates• Responsible for the systematic large scale protein complex purification and the design and implementation of custom made biochemical assays depending upon project needs • Provided leadership for project initiation and guidance on the strategic directions of the company • Substantial contributions to establish and ran research collaborations with 2 pharmaceutical companies

Freiburg; Germany

Wnt Pathway; beta-catenin biology.